The role of FGFR2 amplification and expression in patients with advanced or metastatic gastric cancer receiving fluoropyrimidine-based chemotherapy

被引：0
|
作者：
Skupinska, M. M. [1 ]
Jesiotr, M. [2 ]
Chrom, P. [3 ]
Mroz, A. [4 ]
Cierniak, S. [2 ]
Winiarek, M. [5 ]
Wyrwicz, L. S. [5 ]
Pieczykolan, J. [6 ]
Wieczorek, M. [7 ]
Stanczak, A. [1 ]
Bodnar, L. [3 ]
机构：
[1] Celon Pharma, Preclin Dev Dept, Warsaw, Poland
[2] Mil Inst Med, Dept Pathol, Warsaw, Poland
[3] Mil Inst Med, Dept Oncol, Warsaw, Poland
[4] M Sklodowska Curie Mem Canc Ctr & Inst Oncol, Dept Pathol & Lab Diagnost, Warsaw, Poland
[5] M Sklodowska Curie Mem Canc Ctr & Inst Oncol, Dept Oncol & Radiotherapy, Warsaw, Poland
[6] Celon Pharma, Preclin Dev Dept, Lomianki, Poland
[7] Celon Pharma SA, Lomianki, Poland
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
647P
引用
收藏
页码：218 / 218
页数：1
相关论文
共 50 条
  • [41] Expression of autophagy-related proteins is associated with the clinical outcome of patients with advanced gastric cancer receiving fluoropyrimidine/platinum chemotherapy
    Xu, Yanchang
    Huang, Yisen
    Pan, Guofeng
    Li, Zhixiong
    Lin, Linwen
    Chen, Jian
    Wu, Jihuang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (03): : 3735 - 3742
  • [42] Incidence of hand-foot syndrome with capecitabine in combination with chemotherapy as first-line treatment in patients with advanced and/or metastatic gastric cancer suitable for treatment with a fluoropyrimidine-based regimen
    Gomez-Martin, Carlos
    Sanchez, Antonio
    Irigoyen, Antonio
    Llorente, Beatriz
    Perez, Begona
    Serrano, Raquel
    Jose Safont, Ma
    Falco, Esther
    Lacasta, Adelaida
    Reboredo, Margarita
    Aparicio, Jorge
    Duenas, Rosario
    Llanos Munoz, Marta
    Regueiro, Pilar
    Sanchez-Vines, Elena
    Lopez Lopez, Rafael
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2012, 14 (09): : 689 - 697
  • [43] Neutralizing antibody to FGFR2 can act as a selective biomarker and potential therapeutic agent for gastric cancer with FGFR2 amplification
    Kim, Seung Tae
    Lee, In Kyoung
    Rom, Eran
    Sirkis, Roy
    Park, Se Hoon
    Park, Joon Oh
    Park, Young Suk
    Lim, Ho Yeong
    Kang, Won Ki
    Kim, Kyoung-Mee
    Yayon, Avner
    Lee, Jeeyun
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2019, 11 (07): : 4508 - 4515
  • [44] Discovery and Therapeutic Potential of FGFR2 Gene Amplification in Diffuse Gastric Cancer
    Lau, Wen Min
    Zang, Zhi Jiang
    Teng, Eileen
    Das, Kakoli
    Yong, Wei-Peng
    Teh, Ming
    Tan, Jin Wei
    Chia, Li Ming Tania
    Tay, Amy
    Shabbir, Asim
    Kono, Koji
    Chan, Shing Leng
    Tan, Patrick
    So, Jimmy B.
    GASTROENTEROLOGY, 2014, 146 (05) : S151 - S151
  • [45] The efficacy of fluoropyrimidine-based second line chemotherapy in advanced and metastatic pancreatic cancer: Results of an ongoing Italian/Swiss multicenter survey
    Petricca, Andrea Mancuso
    Saletti, Piercarlo
    Tronconi, Maria Chiara
    Aprile, Giuseppe
    Milesi, Laura
    Aglione, Stefania
    Fatigoni, Sonia
    Garassino, Marina
    Labianca, Roberto
    Sternberg, Cora N.
    ANNALS OF ONCOLOGY, 2006, 17 : 323 - 323
  • [46] Phase 2 study of futibatinib in patients with specific FGFR aberrations: Activity in patients with gastric or gastroesophageal junction cancer harboring FGFR2 amplification
    Satoh, T.
    Barthelemy, P.
    Nogova, L.
    Honda, K.
    Iwasa, S.
    Lee, K.
    Rha, S.
    Ajani, J.
    Hangai, N.
    Liu, S.
    Kremer, J.
    Mina, M.
    Shitara, K.
    ANNALS OF ONCOLOGY, 2023, 34 : S165 - S166
  • [47] Prediction of clinical outcome of fluoropyrimidine-based chemotherapy for gastric cancer patients, in terms of the 5-fluorouracil metabolic pathway
    Ichikawa W.
    Gastric Cancer, 2006, 9 (3) : 145 - 155
  • [48] Upfront DPYD Genotype-Guided Treatment for Fluoropyrimidine-Based Chemotherapy in Advanced and Metastatic Colorectal Cancer: A Cost-Effectiveness Analysis
    Fariman, Soroush Ahmadi
    Rafsanjani, Zahra Jahangard
    Hasanzad, Mandana
    Niksalehi, Kimia
    Nikfar, Shekoufeh
    VALUE IN HEALTH REGIONAL ISSUES, 2023, 37 : 71 - 80
  • [49] Prognostic value of microsatellite instability and p53 expression in metastatic colorectal cancer treated with oxaliplatin and fluoropyrimidine-based chemotherapy
    Noepel-Duennebacke, S.
    Schulmann, K.
    Reinacher-Schick, A.
    Porschen, R.
    Schmiegel, W.
    Tannapfel, A.
    Graeven, U.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2014, 52 (12): : 1394 - 1401
  • [50] Intratumoral Cox-2 gene expression is a predictive factor for colorectal cancer response to fluoropyrimidine-based chemotherapy
    Uchida, K
    Schneider, S
    Yochim, JM
    Kuramochi, H
    Hayashi, K
    Takasaki, K
    Yang, DY
    Danenberg, KD
    Danenberg, PV
    CLINICAL CANCER RESEARCH, 2005, 11 (09) : 3363 - 3368
12345